Skip to main content
. Author manuscript; available in PMC: 2013 Apr 29.
Published in final edited form as: J Steroid Biochem Mol Biol. 2004 Jan;88(1):101–110. doi: 10.1016/j.jsbmb.2003.11.002

Fig. 4.

Fig. 4

The effect of MAP-kinase-kinase inhibitor; UO126 on estradiol 17β (0.3 or 300 nM)-dependent 3[H] thymidine incorporation in VSMC and in E304 cells. Results are means ± S.E.M. of 4–12 incubates from 2 to 4 experiments and are expressed as the ratio between 3[H] thymidine incorporation in hormone-treated and control cells. * P < 0.05; ** P < 0.01 for the comparison with control values; # P < 0.05 for the comparison with control values in the presence of UO126; and a P < 0.05; b P < 0.01 for the comparison between the effect of E2 with and without UO126. The statistical analysis was done by ANOVA.